April 2026 The FDA Moves to Close the Door Permanently On April 30, 2026 , the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List the list of active ingredients large-scale outsourcing facilities are legally permitted to compound from
Act on the brain to decrease hunger, increase satisfaction, and alter the food-reward system (changing food preferences in favor of healthier options.) Improves the bodys response to insulin, a term called insulin sensitivity, which has a positive effect on both blood sugar levels and weight loss.[1] For a more detailed explanation of how GLP-1 medications work to cause weight loss, you can check out our article What does semaglutide do to the body?
If you have type 2 diabetes, youre likely a good candidate for Ozempic, as this is its primary FDA-approved indication
[16] This external analysis uses medical claims data for 3,364 people with commercial health plans that cover GLP-1 drugs
We want you to feel confident that youve partnered with the right team for your journey